Suppr超能文献

A激酶锚定蛋白在脂蛋白脂肪酶组织特异性调节中的作用。

Role of A kinase anchor proteins in the tissue-specific regulation of lipoprotein lipase.

作者信息

Ranganathan Gouri, Pokrovskaya Irina, Ranganathan Subramanian, Kern Philip A

机构信息

The Central Arkansas Veterans Healthcare System, and Department of Medicine, Division of Endocrinology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

出版信息

Mol Endocrinol. 2005 Oct;19(10):2527-34. doi: 10.1210/me.2005-0144. Epub 2005 Jun 16.

Abstract

Activation of protein kinase A by catecholamines inhibits lipoprotein lipase (LPL) activity through the elaboration of an RNA binding complex, which inhibits LPL translation by binding to the 3'-untranslated region of the LPL mRNA. To better define this process, we reconstituted the inhibitory RNA binding complex in vitro and demonstrated that the K homology (KH) domain of A kinase anchor protein (AKAP) 121/149 plays a vital role in the inhibition of LPL translation. Inhibition of LPL translation occurred in vitro only when the Calpha subunit, R subunit, and AKAP 149 were present. Using different glutathione-S-transferase fusion proteins of AKAP 149, sequences containing the KH domain were required for inhibition of LPL translation, and the inhibition of AKAP 121 expression in 3T3-F442A adipocytes with short interfering RNA resulted in loss of epinephrine-mediated translation inhibition. After epinephrine injection into mice, LPL activity was inhibited in white adipose tissue but not in brown adipose tissue (BAT) or muscle. LPL activity and synthetic rate were inhibited in vitro by the addition of epinephrine to 3T3-F442A adipocytes, but there was no effect in L6 muscle cells and cultures of brown adipocytes. Corresponding with these differences in LPL translation, AKAP 121 protein and mRNA were abundantly expressed in mouse white adipose tissue, but was either very low or undetectable in BAT and muscle. Thus, AKAP 121/149 contains a KH region that is essential to the translation inhibition of LPL in response to epinephrine. BAT and muscle do not express significant AKAP 121/149, and this likely explains some of the tissue-specific differences in LPL regulation.

摘要

儿茶酚胺激活蛋白激酶A会通过一种RNA结合复合物的形成来抑制脂蛋白脂肪酶(LPL)的活性,该复合物通过与LPL mRNA的3'非翻译区结合来抑制LPL的翻译。为了更好地定义这一过程,我们在体外重建了抑制性RNA结合复合物,并证明A激酶锚定蛋白(AKAP)121/149的K同源(KH)结构域在抑制LPL翻译中起着至关重要的作用。仅当存在Cα亚基、R亚基和AKAP 149时,LPL翻译的抑制才会在体外发生。使用AKAP 149的不同谷胱甘肽-S-转移酶融合蛋白,抑制LPL翻译需要包含KH结构域的序列,并且用短发夹RNA抑制3T3-F442A脂肪细胞中AKAP 121的表达会导致肾上腺素介导的翻译抑制丧失。给小鼠注射肾上腺素后,白色脂肪组织中的LPL活性受到抑制,但棕色脂肪组织(BAT)或肌肉中则没有。向3T3-F442A脂肪细胞中添加肾上腺素可在体外抑制LPL活性和合成速率,但对L6肌肉细胞和棕色脂肪细胞培养物没有影响。与LPL翻译中的这些差异相对应,AKAP 121蛋白和mRNA在小鼠白色脂肪组织中大量表达,但在BAT和肌肉中要么非常低要么无法检测到。因此,AKAP 121/149包含一个KH区域,该区域对于响应肾上腺素抑制LPL的翻译至关重要。BAT和肌肉不表达显著水平的AKAP 121/149,这可能解释了LPL调节中一些组织特异性差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验